Oxford Biodynamics PLC
OTC:OXBOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Oxford Biodynamics PLC (OXBOF) under the Base Case is 0.001 USD per share.
Compared with the current market price of 0.003 USD, the stock appears
Overvalued by 76% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Oxford Biodynamics Does
Oxford Biodynamics is a biotechnology company that develops blood-based tests using its EpiSwitch platform, which looks at how DNA is folded in the cell to find disease signals. The company’s core work is to discover and validate biomarkers that can help identify cancer and other serious diseases earlier or more accurately than standard tests.
- Headquarters
- United Kingdom UK
- Employees
- 41
- IPO date
- Dec 6, 2016
Balance Sheet
Continue OXBOF Research
Decided on Oxford Biodynamics? Get an email when OXBOF reaches the price you’d buy at. Free with an account.
Other Oxford Biodynamics listings
What is the Intrinsic Value of one OXBOF stock?
The intrinsic value for
Oxford Biodynamics PLC (OXBOF) under the Base Case is 0.001 USD.
Is OXBOF stock undervalued or overvalued?
Compared with the current market price of 0.003 USD, the stock appears Overvalued by 76% .